LSP’s leading €27 mln Series A financing of new VIB start-up Aelin Therapeutics

Paolo Bossi

Aelin Therapeutics, a privately held Belgian biotherapeutics company, announces that it has secured a EUR 27 million investment to pioneer a novel modality in drug development…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here